The FDA has approved a new nasal spray to treat migraine headaches in adults. The spray, which is said to be fast-acting and provide relief within a short time frame, is reportedly the first of its kind. However, there is some uncertainty about the specific name and details of the treatment, with different reports referring to it as Zavzpret, STS101, or simply a gepant.